Montironi R - Search Results

1

Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution.

Mollica V, Di Nunno V, Gatto L, Santoni M, Cimadamore A, Cheng L, Lopez-Beltran A, Montironi R, Pisconti S, Battelli N, Massari F. Mollica V, et al. Among authors: montironi r. Clin Drug Investig. 2019 Jun;39(6):503-519. doi: 10.1007/s40261-019-00773-w. Clin Drug Investig. 2019. PMID: 30937824 Review.

2

Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation.

Lopez-Beltran A, Cheng L, Andersson L, Brausi M, de Matteis A, Montironi R, Sesterhenn I, van det Kwast KT, Mazerolles C. Lopez-Beltran A, et al. Among authors: montironi r. Virchows Arch. 2002 Jan;440(1):3-11. doi: 10.1007/s00428-001-0577-6. Virchows Arch. 2002. PMID: 11942574 Review.

3

Evaluation of prognostic factors in radical prostatectomy specimens with cancer.

Mazzucchelli R, Santinelli A, Lopez-Beltran A, Scarpelli M, Montironi R. Mazzucchelli R, et al. Among authors: montironi r. Urol Int. 2002;68(4):209-15. doi: 10.1159/000058437. Urol Int. 2002. PMID: 12053019 Review.

4

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.

Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R. Lopez-Beltran A, et al. Among authors: montironi r. Eur Urol. 2004 Mar;45(3):257-66. doi: 10.1016/j.eururo.2003.09.018. Eur Urol. 2004. PMID: 15036668 Review.

5

Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptors.

Montironi R, Scarpelli M, López Beltran A. Montironi R, et al. Virchows Arch. 2004 Jun;444(6):503-8. doi: 10.1007/s00428-004-0996-2. Epub 2004 Mar 26. Virchows Arch. 2004. PMID: 15045584 Review.

6

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working Group.

Lopez-Beltran A, Bassi PF, Pavone-Macaluso M, Montironi R; European Society of Uropathology; Uropathology Working Group. Lopez-Beltran A, et al. Among authors: montironi r. Virchows Arch. 2004 Aug;445(2):103-10. doi: 10.1007/s00428-004-1039-8. Epub 2004 Jun 8. Virchows Arch. 2004. PMID: 15185074 Review.

7

Non-invasive urothelial neoplasms: according to the most recent WHO classification.

Lopez-Beltran A, Montironi R. Lopez-Beltran A, et al. Among authors: montironi r. Eur Urol. 2004 Aug;46(2):170-6. doi: 10.1016/j.eururo.2004.03.017. Eur Urol. 2004. PMID: 15245809 Review.

8

Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.

Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena MJ, Montironi R. Lopez-Beltran A, et al. Among authors: montironi r. Am J Clin Pathol. 2004 Sep;122(3):444-52. doi: 10.1309/LTFU-3UUM-BY09-5HUM. Am J Clin Pathol. 2004. PMID: 15362377

9

The 2004 WHO classification of bladder tumors: a summary and commentary.

Montironi R, Lopez-Beltran A. Montironi R, et al. Int J Surg Pathol. 2005 Apr;13(2):143-53. doi: 10.1177/106689690501300203. Int J Surg Pathol. 2005. PMID: 15864376 Review.

10

Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype.

Lopez-Beltran A, Qian J, Montironi R, Luque RJ, Bostwick DG. Lopez-Beltran A, et al. Among authors: montironi r. Int J Surg Pathol. 2005 Apr;13(2):167-73. doi: 10.1177/106689690501300207. Int J Surg Pathol. 2005. PMID: 15864380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,021 results

Search Page

Filters